4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-26-112065
Chief Medical Officer sold 10,853 shares at $36.57 ($396,894)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Karlin Daniel · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-25 | Sale : show line 1 in the form 10b5-1 | −10,853 | $36.57 | $396,894 | 792,846 | D |
| Open-market sales · 10,853 sh · avg $36.57 · $396,894 | ||||||
Loading xslF345X06/tm2626627-5_4seq1.xml…